Daiichi Sankyo, Inc. (DSI), announced that results from the pivotal study supporting the use of colesevelam HCl in pediatric patients with heterozygous familial hypercholesterolemia (heFH), were presented for the first time at the American H
External Link Source » http://www.medicalnewstoday.com
External Link Source » http://www.medicalnewstoday.com
HealthCareInternational.Net?
HealthCare International is a social health care related news, articles & blog aggregation system.
Most Popular Published
Explore Health Care Intl.
Latest Comments
Last 10 Users










Comments